Novavax EVP files Form 3 equity holdings
NOVAVAX INC executive Robert Edward Walker, EVP, R&D, filed an initial ownership report showing equity awards and common stock holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
NOVAVAX INC executive Robert Edward Walker, EVP, R&D, filed an initial ownership report showing equity awards and common stock holdings. The filing lists stock options to purchase 11,500 shares of common stock at $6.97 expiring on March 7, 2033, 22,510 shares at $10.11 expiring on March 3, 2035, and 18,826 shares at $8.39 expiring on March 2, 2036.
He also holds restricted stock units covering 47,600, 29,490 and 26,300 shares of common stock, plus 34,386 shares of common stock directly. Footnotes describe standard vesting schedules over three to four years, tied to continued employment.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
Walker Robert Edward
Role
EVP, R&D
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 52,836 contracts (Direct);
Restricted Stock Units — 103,390 contracts (Direct);
Common Stock — 34,386 shares (Direct)
Footnotes (6)
- F1. Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), vested on the first anniversary of the March 7, 2023 grant date, and the remaining seventy-five percent (75%) of the shares vested or will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.
- F2. The RSUs subject to this grant under the Plan vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment with the Company through such vesting date.
- F3. Twenty-five percent (25%) of the shares subject to this option grant under the Plan vested on the first anniversary of the March 3, 2025 grant date, and the remaining seventy-five percent (75%) of the shares vested or will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.
- F4. The RSUs subject to this grant under the Plan vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 3, 2025 grant date, in each case subject to continued employment with the Company through such vesting date.
- F5. Twenty-five percent (25%) of the shares subject to this option grant under the Plan vested on the first anniversary of the March 2, 2026 grant date, and the remaining seventy-five percent (75%) of the shares vested or will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.
- F6. The RSUs subject to this grant under the Plan vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 2, 2026 grant date, in each case subject to continued employment with the Company through such vesting date.
Key Figures
Option grant 1: 11,500 shares at $6.97
Option grant 2: 22,510 shares at $10.11
Option grant 3: 18,826 shares at $8.39
+4 more
7 metrics
Option grant 1
11,500 shares at $6.97
Stock option, expires March 7, 2033
Option grant 2
22,510 shares at $10.11
Stock option, expires March 3, 2035
Option grant 3
18,826 shares at $8.39
Stock option, expires March 2, 2036
RSU grant 1
47,600 underlying shares
Restricted Stock Units under Plan
RSU grant 2
29,490 underlying shares
Restricted Stock Units under Plan
RSU grant 3
26,300 underlying shares
Restricted Stock Units under Plan
Direct common stock
34,386 shares
Directly held Novavax common stock
Key Terms
Stock Option (Right to Buy), Restricted Stock Units, Amended and Restated 2015 Stock Incentive Plan, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" with underlying common stock"
Restricted Stock Units financial
"security_title: "Restricted Stock Units" with underlying common stock shares"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated 2015 Stock Incentive Plan financial
"option grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan"
vesting financial
"shares vested or will vest in equal monthly installments over three years"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continued employment financial
"subject to continued employment with the Company through such vesting date"
Continued employment means that an individual remains in their current job without interruption. For investors, it signals stability and ongoing work that can affect company performance and future prospects. Like a steady heartbeat for a business, sustained employment helps ensure consistent operations and financial health.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Novavax (NVAX) Form 3 filing by Robert Edward Walker show?
The Form 3 shows EVP, R&D Robert Edward Walker’s initial equity holdings in Novavax, including stock options, restricted stock units (RSUs), and directly held common shares, providing transparency into his compensation-related ownership position at the company.
How many Novavax (NVAX) stock options does Robert Walker report on Form 3?
Robert Walker reports stock options linked to 11,500 shares at $6.97, 22,510 shares at $10.11, and 18,826 shares at $8.39 per share. These options expire on March 7, 2033, March 3, 2035, and March 2, 2036, respectively, and relate to Novavax common stock.
What restricted stock unit (RSU) holdings are disclosed for Robert Walker in Novavax (NVAX)?
He holds RSUs tied to 47,600, 29,490, and 26,300 Novavax common shares. Footnotes state these RSUs vest in one-third annual installments over three years from grant dates in March 2024 and March 2025, subject to continued employment with the company through each vesting date.
What are the vesting terms for Robert Walker’s Novavax (NVAX) stock options?
For each option grant, 25% of the shares vested on the first anniversary of the grant date, with the remaining 75% vesting in equal monthly installments over the following three years. Vesting under the Novavax 2015 Stock Incentive Plan depends on continued employment at each vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates